期刊文献+

伪肽策略在DNA嵌插剂设计中的应用

Design of DNA intercalators:a strategy of pseudopeptides
下载PDF
导出
摘要 DNA嵌插剂是临床上非常重要的一类抗肿瘤药物。在过去的几十年里,大量策略被用于DNA嵌插剂设计。其中伪肽策略由于高抗肿瘤疗效和低神经毒性而得到广泛关注。本文综述了伪肽策略的最新进展,包括结构多样性,三维定量构效关系,与DNA的分子对接,及一些评价抗肿瘤活性或嵌插分子机制的实用的物理化学方法,例如紫外光谱、荧光光谱、圆二色散光谱、DNA黏度和热变性温度实验研究方法。 In anti-tumor therapy DNA intercalators are of clinical importance.In the past few decades a number of strategies were used for intercalator design,of the reported strategies pseudo-peptides were specifically designed as a promising strategy,mainly due to their high anti-tumor efficacy and low neural toxicity.In this case,the present paper reviewed the recent progress of pseudo-peptides including their structural diversity,their 3D QSAR,and their docking towards DNA.To emphasize the utility some chemical physical methods either for evaluating the anti-tumor activity or for exploring the molecular mechanism,such as the UV,CD and fluorescence spectra,as well as the temperature melting and viscosity,which reflect the interaction of pseudo-peptide with DNA,were also mentioned.
出处 《转化医学研究(电子版)》 2012年第3期55-75,共21页 Translational Medicine Research(Electronic Edition)
基金 多肽与小分子药物北京市重点实验室 首都医科大学校长基金(11JYY16) 首都医科大学学生实践创新能力培养建设项目的支持~~
关键词 伪肽 嵌插剂 抗肿瘤 机制研究 pseudo-peptides,intercalation,anti-tumor,mechanism
  • 相关文献

参考文献50

  • 1Lerman LS. Structural considerations in the interaction of DNA and acridines[J].Journal of Molecular Biology,1961,(01):18-30.
  • 2Wilson WD,Jones R,Whittingham MS. Intercalation chemistry[M].New York:Academic Press,Inc,1981.
  • 3Denny WA,Baguley BC,Cain BF. Mechanism of action of anticancer drugs[M].London:Macmillan,1983.
  • 4Foye WO. Cancer chemotherapeutic agents[M].Washington,DC:American Chemical Society,1995.
  • 5Propst CL,Perun TL. Nucleic acid targeted drug design[M].New York,USA:Marcel Dekker,Inc,1992.
  • 6Momekov G,Bakalova A,Karavanova M. Novel approaches towards development of non-classical platinum-based antineoplastic agents:design of platinum complexes characterized by an alternative DNA-binding pattern and/or tumor-targeted cytotoxicity[J].Current Medicinal Chemistry,2005,(19):2177-2191.
  • 7Bolognese A,Correale G,Manfra M. Design,synthesis,and biological evaluation of new pyridoisoquinolindion and dihydrothienoquinolindi-one derivatives with potent cytotoxic activity[J].Journal of Medicinal Chemistry,2004,(04):849-858.doi:10.1021/jm030918b.
  • 8Zheng MQ,Zhao M,Peng SQ. A class of novel N-Isoquinoline-3-carbonyl-L-amino acid benzylesters:synthesis,anti-tumor evaluation and 3D QSAR analysis[J].European Journal of Medicinal Chemistry,2011,(05):1672-1681.
  • 9Ortín I,Gonzalez JF,de la Cuesta E. Pyrazino[1,2-b] isoquinolines:Synthesis and study of their cytostatic and cytotoxic properties[J].Bioorganic and Medicinal Chemistry Letters,2008,(19):9065-9078.
  • 10Charupant K,Daikuhara N,Saito E. Chemistry of renieramycins,part 8:synthesis and cytotoxicity evaluation of renieramycin M-jorunnamycin A analogues[J].Bioorganic and Medicinal Chemistry Letters,2009,(13):4548-4558.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部